Arrowhead Pharmaceuticals
ARWR
#2767
Rank
A$9.03 B
Marketcap
A$63.92
Share price
-2.76%
Change (1 day)
3.37%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2026 (TTM): -A$0.23 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are A$0.66 Billion. In 2025 the company made an earning of A$0.51 Billion, an increase over its 2024 earnings that were of -A$0.9 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.23 Billion-143.71%
2025 A$0.51 B-157.5%
2024 -A$0.9 Billion112.45%
2023 -A$0.43 Billion87.79%
2022 -A$0.23 Billion-20.1%
2021 -A$0.28 Billion67.59%
2020 -A$0.17 Billion-347.53%
2019 A$67.49 M-245.59%
2018 -A$46.36 Million-13.17%
2017 -A$53.4 Million-52.28%
2016 -A$0.12 Billion-16.57%
2015 -A$0.14 Billion30.32%
2014 -A$0.11 Billion171.62%
2013 -A$37.89 Million16.56%
2012 -A$32.51 Million107.53%
2011 -A$15.67 Million
2008 -A$55.18 Million-8.07%
2007 -A$60.02 Million70.37%
2006 -A$35.23 Million122.51%
2005 -A$15.84 Million147.41%
2004 -A$6.4 Million2002.28%
2003 -A$0.31 Million-85.61%
2002 -A$2.12 Million1371.97%
2001 -A$0.15 Million-13.45%
2000 -A$0.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.83 B-11,839.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-A$4.53 Billion 1,809.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$90.56 M-138.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.18 Billion-26.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.81 B-865.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-A$0.13 Billion-48.39%๐Ÿ‡บ๐Ÿ‡ธ USA